CAS: 1956366-10-1 - 1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-, hydrochloride (1:1)

Fórmula: C₂₁H₂₂Cl₂N₄O₂.ClH

InChI: InChI=1S/C21H22Cl2N4O2.ClH/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13;/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29);1H/t19-;/m1./s1

Chave InChI: InChIKey=DKGYQCPFBWFTHM-FSRHSHDFSA-N

SMILES: Cl.O=C(NC(C=1C=CC=C(Cl)C1)CO)C2=CC(=CN2)C=3C=C(N=CC3Cl)NC(C)C

Ulixertinib hydrochloride

CAS: 1956366-10-1

• Fórmula: C₂₁H₂₃Cl₃N₄O₂
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 469.7919

Ulixertinib hydrochloride

CAS: 1956366-10-1

• Peso molecular: 469.79g/mol

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib (BVD-523) orally inhibits ERK1/2, reducing VEGF, myeloma growth, and angiogenesis.

• Fórmula: C₂₁H₂₃Cl₃N₄O₂
• Cor e Forma: Solid
• Peso molecular: 469.79

Ulixertinib Hydrochloride

CAS: 1956366-10-1

• Fórmula: C₂₁H₂₂Cl₂N₄O₂(HCl)
• Cor e Forma: Neat
• Peso molecular: 433.333646

Ulixertinib hydrochloride

CAS: 1956366-10-1

Ulixertinib is an investigational drug, which is an inhibitor of the receptor tyrosine kinase MET. …

• Fórmula: C₂₁H₂₃Cl₃N₄O₂
• Pureza: Min. 95%
• Peso molecular: 469.79 g/mol